Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-09-15 | 2023-10-27 | 204405 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-11-17 | 2023-12-15 | 210656 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-12-08 | 2023-12-15 | 212931 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-07-26 | 2018-03-15 | 17251 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-01-18 | 2021-02-26 | 131875 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-03-05 | 2018-06-08 | 41852 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-10-19 | 2019-01-10 | 64938 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69307 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-06-27 | 2022-08-24 | 163448 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2022-07-15 | 2022-08-24 | 164710 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-08-19 | 2022-08-24 | 167416 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-11-20 | 2022-12-23 | 175321 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-10-03 | 2018-03-15 | 24262 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-02-02 | 2023-06-23 | 183477 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2023-04-14 | 2023-06-23 | 189641 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-05-25 | 2021-10-05 | 139845 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2021-08-27 | 2021-10-01 | 144659 |
| APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.25% | 0.25% | LIQUID | Actual shortage | 2017-08-13 | 2017-10-05 | 19096 |
| APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.5% | 0.5% | LIQUID | Actual shortage | 2017-08-13 | 2017-10-05 | 19093 |
| APO-LEVOCARB | 25MG 250MG | TABLET | Resolved | 2017-08-23 | 2017-11-09 | 20108 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-08-06 | 217493 |
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
| APO-CEFPROZIL | 500MG | TABLET | Discontinued | 2018-04-04 | 2018-10-05 | 44945 |
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Discontinued | 2018-12-20 | 2018-12-21 | 70250 |
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |